• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor, pharmacist, or nurse.
• This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
• If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

1. What Cozaar Comp is and what it is used for
2. What you need to know before you take Cozaar Comp
3. How to take Cozaar Comp
4. Possible side effects
5. How to store Cozaar Comp
6. Contents of the pack and other information

• if you are allergic to losartan, hydrochlorothiazide or to any of the other ingredients of this medicine (listed in section 6),
• if you are allergic to other sulfonamide-derived substances (e.g. other thiazides, some antibacterial drugs such as co-trimoxazole, ask your doctor if you are not sure),
• if you have severely impaired liver function,
• if you have low potassium, low sodium or high calcium levels which cannot be corrected by treatment,
• if you are suffering from gout,
• if you are more than 3 months pregnant (It is also better to avoid Cozaar Comp in early pregnancy - see Pregnancy section),
• if you have severely impaired kidney function or your kidneys are not producing any urine,
• if you have diabetes or impaired kidney function and you are treated with a blood pressure lowering medicine containing aliskiren.

Talk to your doctor, pharmacist, or nurse before taking Cozaar Comp.

If you experience a decrease in vision or eye pain. These could be symptoms of fluid accumulation in the vascular layer of the eye (choroidal effusion) or an increase of pressure in your eye and can happen within hours to weeks of taking Cozaar Comp. This can lead to permanent vision loss, if not treated. If you earlier have had a penicillin or sulfonamide allergy, you can be at higher risk of developing this.

You must tell your doctor if you think you are (or might become) pregnant. Cozaar Comp is not recommended in early pregnancy, and must not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if used at that stage (see pregnancy section).

It is important to tell your doctor before taking Cozaar Comp:

• if you experienced breathing or lung problems (including inflammation or fluid in the lungs) following hydrochlorothiazide intake in the past. If you develop any severe shortness of breath or difficulty breathing after taking Cozaar Comp, seek medical attention immediately;
• if you have previously suffered from swelling of the face, lips, throat or tongue;
• if you take diuretics (water pills);
• if you are on a salt-restricted diet;
• if you have or have had severe vomiting and/or diarrhoea;
• if you have heart failure;
• if your liver function is impaired (see section 2 “Do not take Cozaar Comp”);
• if you have narrow arteries to your kidneys (renal artery stenosis) or only have one functioning kidney, or you have recently had a kidney transplant;
• if you have narrowing of the arteries (atherosclerosis), angina pectoris (chest pain due to poor heart function);
• if you have ‘aortic or mitral valve stenosis’ (narrowing of the valves of the heart) or ‘hypertrophic cardiomyopathy’ (a disease causing thickening of heart muscle);
• if you are diabetic;
• if you have had gout;
• if you have or have had an allergic condition, asthma or a condition that causes joint pain, skin rashes and fever (systemic lupus erythematosus);
• if you have high calcium or low potassium levels or you are on a low potassium diet;
• if you need to have an anaesthetic (even at the dentist) or before surgery, or if you are going to have tests to check your parathyroid function, you must tell the doctor or medical staff that you are taking losartan potassium and hydrochlorothiazide tablets;
• if you suffer from primary hyperaldosteronism (a syndrome associated with increased secretion of the hormone aldosterone by the adrenal gland, caused by an abnormality within the gland);
• if you are taking any of the following medicines used to treat high blood pressure:
  • an ACE-inhibitor (for example enalapril, lisinopril, ramipril), in particular if you have diabetes-related kidney problems;
  • Aliskiren.
    Your doctor may check your kidney function, blood pressure, and the amount of electrolytes (e.g. potassium) in your blood at regular intervals.
    See also information under the heading “Do not take Cozaar Comp”;
• if you are taking other medicines that may increase serum potassium (see section 2 “Other medicines and Cozaar Comp”).
• if you have had skin cancer or if you develop an unexpected skin lesion during the treatment. Treatment with hydrochlorothiazide, particularly long term use with high doses, may increase the risk of some types of skin and lip cancer (non-melanoma skin cancer). Protect your skin from sun exposure and UV rays while taking Cozaar Comp.

There is no experience with the use of Cozaar Comp in children. Therefore, Cozaar Comp should not be given to children.

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.

Tell your doctor if you are taking potassium supplements, potassium-containing salt substitutes, potassium-sparing medicines, or other medicines that may increase serum potassium (e.g., trimethoprim-containing medicines), as the combination with Cozaar Comp is not advisable.

Diuretic agents such as the hydrochlorothiazide contained in Cozaar Comp may interact with other medicines.

Preparations containing lithium should not be taken with Cozaar Comp without close supervision by your doctor.

Special precautionary measures (e.g. blood tests) may be appropriate if you take other diuretics (“water tablets”), some laxatives, medicines for the treatment of gout, medicines to control heart rhythm or for diabetes (oral agents or insulins).

It is also important for your doctor to know if you are taking:

• other medicines to reduce your blood pressure;
• steroids;
• medicines to treat cancer;
• pain killers;
• drugs for treatment of fungal infections;
• arthritis medicines;
• resins used for high cholesterol, such as colestyramine;
• medicines which relax your muscles;
• sleeping tablets;
• opioid medicines such as morphine;
• ‘pressor amines’ such as adrenaline or other drugs from the same group;
• oral agents for diabetes or insulins;

Your doctor may need to change your dose and/or to take other precautions:

If you are taking an ACE-inhibitor or aliskiren (see also information under the headings “Do not take Cozaar Comp” and “Warnings and precautions”).

Please also inform your doctor you are taking Cozaar Comp if you will be undergoing a radiographic procedure and will be given iodine contrast media.

You are advised not to drink alcohol whilst taking these tablets: alcohol and Cozaar Comp tablets may increase each other’s effects.

Dietary salt in excessive quantities may counteract the effect of Cozaar Comp tablets.

Cozaar Comp tablets may be taken with or without food.

Grapefruit juice should be avoided while taking Cozaar Comp tablets.

Pregnancy

You must tell your doctor if you think you are (or might become) pregnant. Your doctor will normally advise you to stop taking Cozaar Comp before you become pregnant or as soon as you know you are pregnant and will advise you to take another medicine instead of Cozaar Comp. Cozaar Comp is not recommended during pregnancy, and must not be taken when more than 3 months pregnant, as it may cause serious harm to your baby if used after the third month of pregnancy.

Breast-feeding

Tell your doctor if you are breast-feeding or about to start breast-feeding. Cozaar Comp is not recommended for mothers who are breast-feeding, and your doctor may choose another treatment for you if you wish to breast-feed.

Cozaar Comp works equally well in and is equally well tolerated by most older and younger adult patients. Most older patients require the same dose as younger patients.

When you begin treatment with this medication, you should not perform tasks which may require special attention (for example, driving an automobile or operating dangerous machinery) until you know how you tolerate your medicine.

If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.

The usual dose of Cozaar Comp for most patients with high blood pressure is 1 tablet of Cozaar Comp 50 mg/12.5 mg per day to control blood pressure over the 24-hour period. This can be increased to 2 tablets once daily of Losartan / Hydrochlorothiazide 50 mg/12.5 mg Film-Coated Tablets or changed to 1 tablet daily of Losartan / Hydrochlorothiazide 100 mg/25 mg Film-Coated Tablets (a stronger strength) per day. The maximum daily dose is 2 tablets per day of Losartan / Hydrochlorothiazide 50 mg/12.5 mg Film-Coated Tablets or 1 tablet daily of Losartan / Hydrochlorothiazide 100 mg/25 mg Film-Coated Tablets.

The tablets should be swallowed whole with a glass of water.

In case of an overdose, contact your doctor immediately so that medical attention may be given promptly. Overdose can cause a drop in blood pressure, palpitations, slow pulse, changes in blood composition, and dehydration.

Try to take Cozaar Comp daily as prescribed. However, if you miss a dose, do not take an extra dose. Just resume your usual schedule.

If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

The active substances are losartan potassium and hydrochlorothiazide.

Cozaar Comp 50 mg/12.5 mg contains 50 mg of losartan potassium and 12.5 mg of hydrochlorothiazide as the active ingredients.

Cozaar Comp 100 mg/12.5 mg contains 100 mg of losartan potassium and 12.5 mg of hydrochlorothiazide as the active ingredients.

Cozaar Comp 100 mg/25 mg contains 100 mg of losartan potassium and 25 mg of hydrochlorothiazide as the active ingredients.

Cozaar Comp 50 mg/12.5 mg, Cozaar Comp 100 mg/12.5 mg and Cozaar Comp 100 mg/25 mg contain the following inactive ingredients:

microcrystalline cellulose (E460), lactose monohydrate, pregelatinised maize starch, magnesium stearate (E572), hydroxypropyl cellulose (E463), hypromellose (E464).

Cozaar Comp 50 mg/12.5 mg contains 4.24 mg (0.108 mEq) of potassium. Cozaar Comp 100 mg/12.5 mg and Cozaar Comp 100 mg/25 mg contain 8.48 mg (0.216 mEq) of potassium.

Cozaar Comp 50 mg/12.5 mg and Cozaar Comp 100 mg/25 mg also contain titanium dioxide (E171), quinoline yellow aluminium lake (E104) and carnauba wax (E903).

Cozaar Comp 100 mg/12.5 mg also contains: titanium dioxide (E171) and carnauba wax (E903).

Cozaar Comp 50 mg/12.5 mg is supplied as yellow, oval film-coated tablets marked 717 on one side and plain or scored on the other. The score line is not intended for breaking the tablet.

Cozaar Comp 100 mg/12.5 mg is supplied as white, oval film-coated tablets marked 745 on one side and plain on the other.

Cozaar Comp 100 mg/25 mg is supplied as light yellow, oval film-coated tablets marked 747 on one side and plain on the other.

Cozaar Comp is supplied in the following pack sizes:

Cozaar Comp 50 mg/12.5 mg - PVC/PE/PVDC blister packages with aluminium foil lidding in cartons containing 4, 7, 10, 14, 20, 28, 30, 50, 56, 84, 98, or 280 tablets and unit-dose packages of 28, 56 and 98 tablets for hospital use. HDPE bottles of 100 tablets.

Cozaar Comp 100 mg/12.5 mg - PVC/PE/PVDC blister packages with aluminium foil lidding in cartons containing 14, 15, 28, 30, 50, 56, 84, 90, 98, 280 tablets. HDPE bottles of 100 tablets.

Cozaar Comp 100 mg/25 mg - PVC/PE/PVDC blister packages with aluminium foil lidding in cartons containing 7, 14, 28, 30, 50, 56, 84, 90, 98, or 280 tablets and unit-dose packages of 28, 56 and 98 tablets for hospital use. HDPE bottles of 100 tablets.

Not all pack sizes may be marketed.

The Marketing Authorisation Holder

Manufacturer:

This medicine is authorised in the Member States of the European Economic Area and in the United Kingdom (Northern Ireland) under the following names:

Member State Invented name

Belgium COZAAR PLUS 50 mg/12,50 mg comprimés pelliculés

Belgium COZAAR PLUS 100 mg/12,50 mg comprimés pelliculés

Belgium COZAAR PLUS FORTE 100 mg/25 mg comprimés pelliculés

Denmark Cozaar Comp.

Denmark Cozaar Comp. 100 mg / 12,5 mg

Denmark Cozaar Comp. Forte

Finland COZAAR Comp

Finland COZAAR Comp Forte

France FORTZAAR 100 mg/25 mg, comprimé pelliculé

France HYZAAR 50 mg/12,5 mg, comprimé pelliculé

France FORTZAAR 100 mg/12,5 mg, comprimé pelliculé

Germany LORZAAR PLUS 50/12,5 mg Filmtabletten

Germany LORZAAR PLUS forte 100/12,5 mg Filmtabletten

Germany FORTZAAR 100/25 mg Filmtabletten

Greece HYZAAR

Greece HYZAAR Forte

Greece HYZAAR Extra Forte

Hungary HYZAAR

Iceland Cozaar Comp

Iceland Cozaar Comp 100 mg/12,5 mg

Iceland Cozaar Comp Forte

Ireland COZAAR Comp 50 mg/12.5 mg film-coated tablets

Ireland COZAAR Comp 100 mg/12.5 mg film-coated tablets

Ireland COZAAR Comp 100 mg/25 mg film-coated tablets

Italy HIZAAR 50 mg + 12,5 mg compresse rivestite con film

Italy HIZAAR 100 mg + 25 mg compresse rivestite con film

Italy FORZAAR 100 mg + 25 mg compresse rivestite con film

Luxembourg COZAAR PLUS 50 mg/12,50 mg comprimés pelliculés

Luxembourg COZAAR PLUS 100 mg/12,50 mg comprimés pelliculés

Luxembourg COZAAR PLUS FORTE 100 mg/25 mg comprimés pelliculés

Netherlands HYZAAR 50/12,5

Netherlands COZAAR Plus 100/12,5

Netherlands FORTZAAR 100/25

Norway Cozaar Comp

Norway Cozaar Comp Forte

Poland HYZAAR

Poland HYZAAR FORTE

Portugal Cozaar Plus

Portugal Fortzaar

Spain COZAAR Plus 50 mg/12,5 mg comprimidos recubiertos con película

Spain FORTZAAR 100 mg/25 mg comprimidos recubiertos con película

Sweden COZAAR Comp 50 mg/12,5 mg filmdragerade tabletter

Sweden COZAAR Comp 100 mg/12,5 mg filmdragerade tabletter

Sweden COZAAR Comp Forte 100 mg/25 mg filmdragerade tabletter

United Kingdom (Northern Ireland) COZAAR Comp 50 mg/12.5 mg film-coated tablets

Member State Invented name

United Kingdom (Northern Ireland) COZAAR Comp 100 mg/12.5 mg film-coated tablets

United Kingdom (Northern Ireland) COZAAR Comp 100 mg/25 mg film-coated tablets